HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Johannes Gebert Selected Research

Transforming Growth Factor-beta Type II Receptor

10/2019TGFBR2‑dependent alterations of microRNA profiles in extracellular vesicles and parental colorectal cancer cells.
8/2019SILAC-Based Quantification of TGFBR2-Regulated Protein Expression in Extracellular Vesicles of Microsatellite Unstable Colorectal Cancers.
1/2017TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells.
1/2016Reconstitution of TGFBR2 in HCT116 colorectal cancer cells causes increased LFNG expression and enhanced N-acetyl-d-glucosamine incorporation into Notch1.
10/2015A new method for detection of tumor driver-dependent changes of protein sialylation in a colon cancer cell line reveals nectin-3 as TGFBR2 target.
1/2015Reconstitution of TGFBR2-Mediated Signaling Causes Upregulation of GDF-15 in HCT116 Colorectal Cancer Cells.
1/2013Transforming growth factor beta receptor 2 (TGFBR2) changes sialylation in the microsatellite unstable (MSI) Colorectal cancer cell line HCT116.
7/2009Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent effect on the cell surface glycan profile.
4/2003Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based detection of microsatellite instabilities in coding DNA sequences: a novel approach to identify DNA-mismatch repair-deficient cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Johannes Gebert Research Topics

Disease

30Neoplasms (Cancer)
06/2022 - 04/2003
26Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 04/2003
12Microsatellite Instability
07/2020 - 01/2004
5Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
10/2021 - 05/2005
5Colonic Neoplasms (Colon Cancer)
01/2019 - 09/2005
5Carcinogenesis
01/2015 - 05/2005
2Turcot syndrome
01/2018 - 04/2007
2Neoplasm Metastasis (Metastasis)
01/2016 - 10/2015
2Melanoma (Melanoma, Malignant)
04/2010 - 07/2009
2Carcinoma (Carcinomatosis)
01/2009 - 11/2004
2Adenoma (Adenomas)
01/2009 - 05/2005
2Endometrial Neoplasms (Endometrial Cancer)
05/2006 - 01/2004
1Stomach Neoplasms (Stomach Cancer)
04/2013
1Glioma (Gliomas)
04/2007
1Hyperplasia
01/2004

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
04/2021 - 09/2003
9Transforming Growth Factor-beta Type II ReceptorIBA
10/2019 - 04/2003
6Calcibiotic Root Canal SealerIBA
07/2020 - 06/2008
5Peptides (Polypeptides)IBA
10/2021 - 09/2003
4Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
08/2019 - 01/2013
4Glycoproteins (Glycoprotein)IBA
10/2015 - 01/2009
3VaccinesIBA
10/2021 - 01/2018
3Transforming Growth Factors (Transforming Growth Factor)IBA
10/2019 - 12/2014
3Polysaccharides (Glycans)IBA
10/2015 - 07/2009
3EpitopesIBA
01/2009 - 09/2003
2Recombinases (Recombinase)IBA
06/2022 - 12/2014
2Nonsense Codon (Nonsense Mutation)IBA
07/2020 - 05/2006
2HLA-A Antigens (HLA-A)IBA
01/2020 - 07/2005
2DNA (Deoxyribonucleic Acid)IBA
11/2015 - 09/2005
2LectinsIBA
03/2015 - 07/2009
2ProteomeIBA
01/2015 - 12/2014
2Myosin Type I (Myosin IA)IBA
04/2013 - 01/2012
2antineoplaston A10 (A 10)IBA
01/2013 - 11/2004
2InterferonsIBA
04/2010 - 12/2007
1Galectin 4 (LGALS4)IBA
06/2022
1Naproxen (Naprosyn)FDA LinkGeneric
10/2021
1Conditioned Culture MediaIBA
02/2021
1MicroRNAs (MicroRNA)IBA
10/2019
1RNA (Ribonucleic Acid)IBA
10/2019
1Glutamine (L-Glutamine)FDA Link
01/2019
1CarbonIBA
01/2019
1Galectins (Galectin)IBA
12/2017
1Stem Cell FactorIBA
01/2017
1Interleukin-4 (Interleukin 4)IBA
01/2017
1CytokinesIBA
01/2017
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
01/2017
1AcetylglucosamineIBA
01/2016
1GlycosyltransferasesIBA
01/2016
1NectinsIBA
10/2015
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
10/2015
1N-Acetylneuraminic Acid (Sialic Acid)IBA
10/2015
1Glucose (Dextrose)FDA LinkGeneric
03/2015
1Deoxyglucose (2 Deoxy D glucose)IBA
03/2015
1AntimetabolitesIBA
03/2015
1MonosaccharidesIBA
03/2015
1Growth Differentiation Factor 15IBA
01/2015
1Doxycycline (Periostat)FDA LinkGeneric
12/2014
1AzidesIBA
12/2014
1Alkynes (Acetylenes)IBA
12/2014
1Activin Receptors (Activin Receptor)IBA
12/2014
1Cycloheximide (Cicloheximide)IBA
04/2013
1DecitabineFDA Link
04/2013
1Messenger RNA (mRNA)IBA
04/2013
1Galectin 3 (LGALS3)IBA
08/2012
1Plant LectinsIBA
08/2012
1AcetylgalactosamineIBA
08/2012
1AgarIBA
01/2012
1CarcinogensIBA
01/2012
1Fibronectins (Fibronectin)IBA
04/2010
1Epithelial Cell Adhesion MoleculeIBA
04/2010
1Transforming Growth Factor beta (TGF-beta)IBA
07/2009
1IntegrinsIBA
07/2009
1Activins (Activin)IBA
07/2009
1Mannose-Binding LectinsIBA
01/2009
1Tyrosine (L-Tyrosine)FDA Link
11/2008
1Protein Tyrosine PhosphatasesIBA
11/2008
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
11/2008
1Amino AcidsFDA Link
05/2006
13' Untranslated Regions (3' UTR)IBA
09/2005
1HLA Antigens (Human Leukocyte Antigens)IBA
07/2005
1Monoclonal AntibodiesIBA
07/2005
1Histocompatibility Antigens Class IIBA
07/2005
1CaspasesIBA
11/2004
1HLA-A*02:01 antigenIBA
11/2004
1Combined VaccinesIBA
11/2004
1beta CateninIBA
10/2004
1AntigensIBA
09/2003
1UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferaseIBA
09/2003

Therapy/Procedure

2Therapeutics
10/2015 - 04/2007
2Lasers (Laser)
05/2005 - 04/2003
1Immunotherapy
04/2021
1Chemoprevention
01/2018
1Adjuvant Chemotherapy
09/2005